Nature Communications (Oct 2016)
Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity
Abstract
Airway hyperreactivity is driven by type 2 cytokines produced by ILC2 and Th2 cells. Here the authors show that an α7-nicotinic receptor agonist (GTS-21) inhibits ILC2 responses and is therapeutic against Alternaria-induced airway hyperreactivity in a humanized mouse model.